Novartis Investigative Site

Maribor, Slovenia 2000

0 studies enrolling now · 2 studies all time

What they study most

IgA Nephropathy, Relapsing Multiple Sclerosis

Studies at this site

• An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab — Completed
• Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients — Completed